Teiko Bio
PrivateLast Round
Series A
Dec 20, 2021
Total Funding Raised
$23.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Teiko Bio is a biotechnology company that provides a precision immune monitoring platform and contract research organization services for clinical trials and diagnostics development.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Healthcare Analytics, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teiko Bio Comparables
Compare Teiko Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IMU Biosciences | 85% | |
| Sirona Dx | 81% | |
| CellCarta | 73% |
Teiko Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 20, 2021 | ||||
| Series A | Oct 5, 2021 | ||||
| Seed | Jul 5, 2021 |
Teiko Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Founders Capital | Series A |
| Alix Ventures | Series A |
| EPIC Ventures | Series A |
| Tau Ventures | Seed |
| Altitude Lab | Seed |
| HOF Capital | Series A |
| Civilization Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 20% QoQ, from 20 to 24 employees.
- Jun 26, 2026
Monthly visitors grew 169% MoM, reaching 12.2K.
Teiko Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Teiko Bio's valuation, stock price, and market status.
Is Teiko Bio a public or private company?
Teiko Bio is a private company.
What is the current stock price of Teiko Bio?
Teiko Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Teiko Bio worth (valuation)?
Valuation information for Teiko Bio is not publicly available.
Can I buy Teiko Bio stock?
Teiko Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Teiko Bio's last funding round?
Teiko Bio's most recent funding round was Series A on December 20, 2021.
Who are the main investors in Teiko Bio?
Key investors in Teiko Bio include HOF Capital.
Will Teiko Bio IPO soon?
No public IPO plans have been announced for Teiko Bio.
How can I track Teiko Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Teiko Bio's secondary market activity and sign up for updates.